BRIDGEWATER, N.J. — Generic drug maker Amneal has introduced four new drugs to the market, all available in tablet form.
The products, approved by the Food and Drug Administration, include:
Lorazepam tablets, a generic version of anxiety treatment Ativan, are available in 0.5-mg, 1-mg and 2-mg strengths, each offered in 100-, 500- and 1,000-count containers;
Meclizine HCl tablets, a generic version of antihistamine Antivert, are available in 12.5-mg and 25-mg strengths in 100-, 500- and 1,000-count bottles;
Promethazine HCl tablets, the generic equivalent of antihistamine Phenergan, are available in strengths of 12.5 mg in 100-count, 25 mg in 100- and 1,000-count and 50 mg in 100-count bottles; and
Venlafaxine HCl tablets, the generic equivalent of antidepressant Effexor, are available in five strengths: 25 mg, 37.5 mg, 50 mg, 75 mg and 100 mg, each in a 90-count bottle.
"We are very pleased with the addition of these four new products to Amneal's portfolio and our continued aggressive growth," Amneal president Chirag Patel said. "Going forward, the pace will accelerate as we add several new dosage forms, introduce complex and unique products and realize the results of our dramatically expanded [research and development] team."